Clinical trial
Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving…
NCT00279565 · Indivior Inc., Industry · Terminated
Key facts
| NCT number | NCT00279565 |
|---|---|
| Title | Buprenorphine Versus Methadone Maintenance in Hepatitis C Patients Receiving Peg-Intron and Rebetol (Study P04279)(TERMINATED) |
| Official title | Randomized, Controlled Study of Buprenorphine and Methadone in Hepatitis C Patients in Need of Treatment |
| Lead sponsor | Indivior Inc., Industry |
| Collaborators | AESCA Pharma GmbH Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C, Chronic |
| Intervention type | Drug |
| Interventions | buprenorphine, methadone, pegylated interferon alfa-2b plus ribavirin |
| Enrollment | 128 |
| Start date | Aug 1, 2005 |
| Primary completion | Feb 1, 2007 |
| Completion | Feb 1, 2007 |
| First posted | Jan 19, 2006 |
| Last update posted | Nov 22, 2012 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: